Literature DB >> 26428230

Characteristics of Transmitted Drug-Resistant HIV-1 in Recently Infected Treatment-Naive Patients in Japan.

Junko Hattori1, Teiichiro Shiino, Hiroyuki Gatanaga, Haruyo Mori, Rumi Minami, Kazue Uchida, Kenji Sadamasu, Makiko Kondo, Wataru Sugiura.   

Abstract

OBJECTIVES: Progress in antiretroviral treatment has led to fewer virological failure cases, but 10%-20% of treatment-naive HIV/AIDS cases are reported to harbor drug-resistant strains, suggesting transmission of drug-resistant HIV. We aimed to determine the trend in prevalence of transmitted drug-resistant (TDR) HIV in Japan, particularly in recently infected patients.
METHODS: Drug-resistance test was performed on 3904 HIV-1-infected cases newly diagnosed between 2007 and 2012. The number of cases infected within 6 months [recent seroconverters (RS)] was estimated by BED assay of 2700 plasma samples. Characteristics of RS cases were further analyzed.
RESULTS: The overall prevalence of TDR was 9.1%, ranging from 7.3% in 2008% to 12.5% in 2010. Among 1403 subtype B/E/D cases with >50 CD4 T cell counts and >1000 HIV copies per milliliter, 468 (33.4%) were estimated to be RS. The prevalence of RS was significantly higher among cases who were male, Japanese, and men who have sex with men. The prevalence of TDR did not differ significantly between recent and long-term seroconverters (8.5% vs. 9.2%, respectively, P = 0.68). Common mutations in both groups were M46I/L and T215 revertants. Furthermore, sequences with these mutations, K103N and D30N/N88D formed clusters on phylogenetic trees.
CONCLUSION: Our study clarified an increase in prevalence of TDR in Japan from 2007 to 2012. The phylogenetic clustering of cases with M46I/L or T215 revertants suggests that HIV with these mutations have become circulating strains. Furthermore, detailed analyses showed that Japanese men who have sex with men are more aware of their risk of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26428230     DOI: 10.1097/QAI.0000000000000861

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand.

Authors:  Donn J Colby; Trevor A Crowell; Sunee Sirivichayakul; Suteeraporn Pinyakorn; Eugene Kroon; Khunthalee Benjapornpong; Jintana Intasan; Rapee Trichavaroj; Sodsai Tovanabutra; Merlin Robb; Praphan Phanuphak; Jintanat Ananworanich; Nittaya Phanuphak
Journal:  J Int AIDS Soc       Date:  2016-10-31       Impact factor: 5.396

Review 2.  Molecular Epidemiology of Human Immunodeficiency Virus.

Authors:  Bum Sik Chin
Journal:  Infect Chemother       Date:  2017-03-22

3.  Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.

Authors:  Xianfeng Wang; Xiaosong Liu; Feng Li; Hong Zhou; Jiefang Li; Yingying Wang; Lihua Liu; Shujun Liu; Yi Feng; Ning Wang
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

4.  HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.

Authors:  Natália Mirele Cantão; Lauana Fogaça de Almeida; Ivan Rodrigo Wolf; Rodrigo Oliveira Almeida; Andressa Alves de Almeida Cruz; Caroline Nunes; Alexandre Naime Barbosa; Guilherme Targino Valente; Maria Inês de Moura Campos Pardini; Rejane Maria Tommasini Grotto
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

5.  HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.

Authors:  Bluma G Brenner; Ruxandra-Ilinca Ibanescu; Maureen Oliveira; Michel Roger; Isabelle Hardy; Jean-Pierre Routy; Fred Kyeyune; Miguel E Quiñones-Mateu; Mark A Wainberg
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

6.  HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.

Authors:  Xianwu Pang; Kailing Tang; Qin He; Jinghua Huang; Ningye Fang; Xinjuan Zhou; Qiuying Zhu; Xiuling Wu; Zhiyong Shen; Shujia Liang
Journal:  BMC Infect Dis       Date:  2021-02-08       Impact factor: 3.090

7.  Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients.

Authors:  Mayumi Imahashi; Hirotaka Ode; Ayumi Kobayashi; Michiko Nemoto; Masakazu Matsuda; Chieko Hashiba; Akiko Hamano; Yoshihiro Nakata; Mikiko Mori; Kento Seko; Masashi Nakahata; Ayumi Kogure; Yasuhito Tanaka; Wataru Sugiura; Yoshiyuki Yokomaku; Yasumasa Iwatani
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China.

Authors:  Hongli Chen; Jing Hu; Chang Song; Miaomiao Li; Yesheng Zhou; Aobo Dong; Ruihua Kang; Jingjing Hao; Jiaxin Zhang; Xiu Liu; Dan Li; Yi Feng; Lingjie Liao; Yuhua Ruan; Hui Xing; Yiming Shao
Journal:  Front Med (Lausanne)       Date:  2022-08-29

9.  Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.

Authors:  Y X Song; R L Xin; Z C Li; H W Yu; W H Lun; J Ye; A Liu; A X Li; J W Li; J Z Ye; M Q Hao; H Y Lu; L J Sun
Journal:  Epidemiol Infect       Date:  2018-01-18       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.